Dermal testing of vaccines for children at high risk of allergies

Vaccine

Volumn 25, Issue 17, 2007, Pages 3454-3463

  Sugai, Kazuko ^a   Shiga, Ayako ^a   Okada, Kenji ^b   Iwata, Tsutomu ^c   Ogura, Hideo ^d   Maekawa, Kihei ^e   Yokota, Shumpei ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b FUKUOKA NATIONAL HOSPITAL   (Japan)

^c TOKYO KASEI UNIVERSITY   (Japan)

^d National Hospital Organization Kochi National Hospital   (Japan)

^e KANAGAWA UNIVERSITY OF HUMAN SERVICES   (Japan)

Author keywords

Allergic children; Dermal test; Vaccination

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN E; INFLUENZA VACCINE; MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE;

ABSENCE OF SIDE EFFECTS; ACCURACY; ALLERGIC DISEASE; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; DILUTION; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; FEMALE; FOOD ALLERGY; HIGH RISK PATIENT; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INFANT; INFLUENZA VACCINATION; INTERMETHOD COMPARISON; INTRACUTANEOUS TEST; LOCAL SKIN REACTION; MAJOR CLINICAL STUDY; MALE; MEASLES VACCINATION; PEDIATRICS; PRESCHOOL CHILD; PRICK TEST; PRIORITY JOURNAL; SCHOOL CHILD; SKIN TEST; UNSPECIFIED SIDE EFFECT; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFANT; INFLUENZA VACCINES; INTRADERMAL TESTS; MALE; MEASLES VACCINE; VACCINES;

EID: 34047225060     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.12.057     Document Type: Article

References (16)

1. Herman J.J., Radin R., and Schneiderman R. Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. J Pediatr 102 (1983) 196-199
2. Ogura H. Allergic diseases-egg allergy and vaccination. J Pediatr Pract 56 (1993) 2209-2216 [in Japanese]
3. Japanese Society of Pediatric Allergy and Clinical Immunology, and Committee for the Study of Prognostic Criteria. Report by the committee for the study of the degree and severity of bronchial asthma attacks and prognostic criteria in small children, vol. 10 (1996), Japanese Society of Pediatric Allergy and Clinical Immunology [p. 114-8, in Japanese]
4. Japan Dermatological Association, and Science Committee of the Japan Dermatological Association. Diagnostic criteria for atopic dermatitis. J Jpn Dermatol Assoc 104 (1994) 1210 [in Japanese]
5. Torii S. Skin tests. Clin Immunol 20 (1988) 223-227 [in Japanese]
6. Special Committee on Vaccination. Japan pediatric information meeting. Guidelines for vaccination (1994) [p. 34, in Japanese]
7. Ogura H., Ogura Y., Tomoda T., Kurashige T., Sakaguchi M., and Inoue S. A pediatric case of anaphylaxis induced by gelatin allergy after measles vaccination. Infect Immun Childhood 7 (1995) 115-118 [in Japanese]
8. Ponvert C., Ardelean-Jaby D., Colin-Gorski A.M., Soufflet B., Hamberger C., de Blic J., et al. Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case-control study based on immediate responses in skin tests and specific IgE determination. Vaccine 14 (2001) 4588-4591
9. Sakaguchi M., Ogura H., and Inoue S. IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines. J Allergy Clin Immunol 96 (1995) 563-565
10. Kelso J.M. The gelatin story. J Allergy Clin Immunol 103 (1999) 200-202
11. Pool V., et al., The VAERS Team. Prevalence of anti-geratin IgE antibodies in people with anaphylaxis after measles-mumps-rubella vaccine in the United States. Pediatrics 110 (2002) e71
12. Jacob T., Ring J., and Udrey M.C. Multiple navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol 108 (2001) 688-696
13. Berger C.L., Vasquez J.G., Shofner J., Mariwalla K., and Edelson R.L. Langerhans cells: mediators of immunity and tolerance. Int J Biochem Cell Biol 38 (2006) 1632-1636
14. Iwata T. Allergic disease and vaccination. Jpn J Pediatr Med 26 (1994) 1907-1911 [in Japanese]
15. Nagafuchi S., Kashiwagi S., Imayama S., Hayashi J., and Niho Y. Intradermal administration of viral vaccines. Rev Med Virol 8 (1998) 97-111
16. Bohlke K., et al., The Vaccine Safety Datalink Team. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 112 (2003) 815-820